Drugs Made In America Acquisition (DMII) Shares Outstanding (Diluted Average) (2024 - 2025)

Drugs Made In America Acquisition (DMII) reported Shares Outstanding (Diluted Average) of $14.4 million for Q4 2025, up 15.41% year-over-year from $12.5 million in Q4 2024, and up 430.91% quarter-over-quarter from $2.7 million in Q3 2025.

Drugs Made In America Acquisition (DMII) Shares Outstanding (Diluted Average) (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has 2 years of Shares Outstanding (Diluted Average) data on file, last reported at $14.4 million in Q4 2025.

  • Shares Outstanding (Diluted Average) for Q4 2025 came in at $14.4 million, up 15.41% year-over-year; the trailing twelve-month figure through Dec 2025 was $14.4 million (up 15.41% YoY), and the FY2025 annual result was $14.4 million, up 15.41% from the prior year.
  • Shares Outstanding (Diluted Average) grew to $14.4 million in Q4 2025 per DMII's latest filing, from $2.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $14.4 million in Q4 2025 and troughed at $2.7 million in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn - 46.95 Mn
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn - 28.75 Mn
3 Berto Acquisition 311.56 Mn 311.56 Mn - 7.50 Mn
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 7.91 Mn
5 Centurion Acquisition 310.21 Mn 310.21 Mn - -
6 WEN Acquisition 309.15 Mn 309.15 Mn - 19.27 Mn
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn - 8.63 Mn
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn - 25.80 Mn
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn - -
10 Drugs Made In America Acquisition 129.34 Mn 129.34 Mn - 14.43 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.43 Mn
Sep 30, 2025 2.72 Mn
Dec 31, 2024 12.50 Mn